The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are Shenzhen Capital Group, Junchenda Capital.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.
Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Hrain Biotechnology
Fund Name | Location |
A15 | Al Qahirah, Cairo, Egypt |
Ajax Strategies | Missouri, St Louis, United States |
Ambridge Capital | - |
AsiaTech Management | California, Cupertino, United States |
Australian Government | Australia, Australian Capital Territory, Canberra |
Binghong Chuangye | China, Henan, Zhengzhou |
Brandless | California, San Francisco, United States |
Broadwing Communication | Austin, Texas, United States |
China Oceanwide | Beijing, Beijing, China |
Chongyisheng | - |
DHC Software | Beijing, Beijing, China |
Dutch Good Growth Fund | - |
INNOventure | Kraków, Malopolskie, Poland |
Jieliyuan Group | - |
Leyi Venture Capital | China, Shanghai |
National Bank of Greece | Athens, Attica, Greece |
Request | Central, Central Region, Singapore |
Sprott Asset Management | Canada, Ontario, Toronto |
The Associated Press | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$30M | 30 Sep 2019 | Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$30M | 30 Sep 2019 | Shanghai |